Pure Global
NCT06384859

Effectiveness of Extracorporeal Shockwave Therapy Combined With Platelet-rich Plasma in the Treatment of Chronic Insertional Achilles Tendinopathy

Mahidol University·Phase 4·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Insertional Achilles Tendinopathy
Drug/Device/Intervention
ESWT
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Mahidol University
Location
Ratchathewi, Thailand
Timeline & enrollment
Phase
Phase 4
Start date
May 01, 2024
End date
May 01, 2027
Enrollment
94 participants
Primary outcome

VAS

Summary

The goal of this clinical trial is to learn about the effectiveness of extracorporeal
 shockwave(ESWT) combined with platelet-rich plasma(PRP) to treat chronic insertional
 tendinopathy. The main questions it aims to answer are:
 
 Does ESWT combined with PRP treatment reduce the symptom and improve functional score after
 treatment? What medical complication do participants have when receive the treatment?
 
 Researchers will compare ESWT combined with PRP to ESWT treatment alone to see if ESWT
 combined with PRP works to treat chronic insertional tendinopathy.
 
 Participants will:
 
 - Receive ESWT once a week for 4 weeks then receive PRP injection at a week later or ESWT
 once a week for 4 weeks
 
 - Visit the clinic at 6 weeks, 3 months, 6 months and 1 year after treatment for checkups
 and record functional score

ICD-10 classifications
Achilles tendinitisInjury of Achilles tendonShort Achilles tendon (acquired)Spontaneous rupture of unspecified tendonInjury of unspecified muscle and tendon at ankle and foot level
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06384859
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06384859 through Pure Global AI's free database. This Phase 4 trial is sponsored by Mahidol University and is currently Not yet recruiting. The study focuses on Insertional Achilles Tendinopathy. Target enrollment is 94 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.